ホールスライドイメージングの世界市場：2023-2030年

世界のホールスライドイメージング市場は、予測期間（2023-2030年）にCAGR 6.4％で成長すると予測されています。同市場の成長の背景には、世界のコンピュータ処理能力の向上があります。強力なコンピュータの開発により、WSIスキャナから生成される膨大な画像の処理と解析が可能になった。画像解析は技術の進歩により、より迅速かつ正確になった。国立衛生研究所（gov.）によると、2023年7月、病理医、病理部門、研究者の間でホールスライドイメージングの利用が増加しています。2018年と2020年に実施された調査によると、従来のガラススライドへのアクセス有無にかかわらず、病理医が一次診断を下す快適さはそれぞれ54％から90％に、23％から60％に増加しました。これは、最先端の光学系やロボット工学、コンピュータ処理能力の向上、データ転送速度、ソフトウェア開発、クラウドストレージソリューションなど、技術の進歩によるところが大きいです。このように、WSIは遠隔病理検査、コンサルテーション、腫瘍ボード、スライドの保存、複数の免疫組織化学染色との比較などに利用されています。

セグメント別の展望

ホールスライドイメージングの世界市場では、スキャナーのサブセグメントが大きなシェアを占めると予測されています。

ホールスライドイメージングの世界市場では、スキャナーのサブセグメントが大きなシェアを占めると予測されています。このセグメントの成長は、世界中でデジタル病理学に対する需要が増加していることに起因しています。デジタル病理学ソリューションに対する需要の増加は、スライドへのリモートアクセス、テレパソロジー、共同分析など、デジタル病理学の利点のほんの一部に過ぎません。病理医や研究者は、NanoZoomer S20MDのようなスキャナーを利用することで、デジタルパソロジーの恩恵を受けることができます。

地域別展望

世界のホールスライドイメージング市場は、さらに北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）に地域別に区分されます。なかでもアジア太平洋地域は、ホールスライドイメージングの利点に対する認識が高まっていることに加え、インドや中国などの一部の国の人口基盤の広さが、同地域の市場成長に寄与していることから、世界全体で大きなシェアを占めると予想されています。

北米地域は世界のホールスライドイメージング市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、世界中の遠隔病理学と遠隔細胞学の発展に起因しています。遠隔細胞診評価で高い感度と特異度を達成した研究の成功は、ヘルスケア改善におけるテレパソロジーの重要性を強調しています。遠隔細胞診を含むテレパソロジーは、病理医が遠隔地からデジタルスライドにアクセスし解釈することを可能にするもので、特に専門医の少ない地域での診断やコンサルテーションを容易にします。MDPIによると、2023年10月、LungenClinic Grosshansdorfで239人の患者に行われた314のRapid Remote Online Cytological Evaluations（154のインプリント細胞診、143の細針吸引、17のブラシ細胞診）を分析しました。遠隔細胞診による現場評価では、所要時間が記録され、所見が細胞・組織学的診断および最終診断と比較されました。その結果、細胞学的良性86例、悪性190例、不明38例の診断が記録されました。診断が不明確であった37検体を除くと、最終診断に関する感度率は90.5％、特異度率は98.5％、正しい分類率は92.4％でした。悪性腫瘍の細胞学的検出の感度率は、細針吸引で76.1％、所見不明の37検体を除くと92.5％でした。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• 3DHISTECH Ltd.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Aiforia Technologies Oyj
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Akoya Biosciences, Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第2章 市場セグメンテーション

• ホールスライドイメージングの世界市場：技術別
  • スキャナー
  • ITインフラ
  • ビューア画像管理システム
• ホールスライドイメージングの世界市場：用途別
  • テレパソロジー
  • 細胞病理学
  • 免疫組織化学
  • 血液病理学
  • その他（神経病理学、法医学病理学）
• ホールスライドイメージングの世界市場：エンドユーザー別
  • ブラシ付きマイクロモーター
  • ブラシレスマイクロモーター
• ホールスライドイメージングの世界市場：エンドユーザー別
  • 学術機関
  • 病院およびヘルスケア機関
  • 製薬研究機関およびCRO（医薬品開発業務受託機関）
  • その他（バイオテクノロジー、製薬会社、政府医療機関）

第3章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域

第4章 企業プロファイル

• CureMetrix, Inc.
• Flagship Biosciences, Inc.
• HAMAMATSU Group
• Huron Digital Pathology
• Indica Labs, Inc.
• Leica Microsystems GmbH
• MBF Bioscience
• Mikroscan Technologies
• Molecular Machines & Industries GmbH
• NIKON CORP.
• Olympus Corp.
• OPAL KELLY INC.
• OptraSCAN Inc.
• PerkinElmer AES
• Philips International B.V.
• Visiopharm A/S
• Zeiss AG

LIST OF TABLES

• 1. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
• 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
• 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 16. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 17. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 18. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
• 19. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION,2022-2030 ($ MILLION)
• 20. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 21. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 22. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
• 23. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION) EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
• 24. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 25. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
• 26. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
• 27. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
• 28. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 29. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION ,2022-2030 ($ MILLION)
• 31. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
• 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY END USER, 2022 VS 2030 (%)
• 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 16. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 17. US WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 18. CANADA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 19. UK WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 20. FRANCE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 21. GERMANY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 22. ITALY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 23. SPAIN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 24. REST OF EUROPE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 25. INDIA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 26. CHINA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 27. JAPAN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 28. SOUTH KOREA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 29. REST OF ASIA-PACIFIC WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
• 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)

Global Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)

The global whole slide imaging market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The market's growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology. According to the National Institute of Health (gov.), in July 2023, the use of whole slide imaging has increased among pathologists, pathology departments, and research scientists. A survey conducted in 2018 and 2020 found that the comfort of pathologists to make a primary diagnosis with or without access to traditional glass slides increased from 54% to 90%, and from 23% to 60%, respectively. This is largely attributed to advancements in technology, including state-of-the-art optics and robotics, increased computer processing power, data transfer speeds, software development, and cloud storage solutions. As such, WSI has been used for telepathology, consultation, tumor boards, archiving slides, and comparisons with multiple immunohistochemical staining.

Segmental Outlook

The global whole slide imaging market is segmented on the technology, application, and end-user. Based on the technology, the market is sub-segmented into scanners, it infrastructure, and viewer image management system. Based on the application, the market is sub-segmented into telepathology, cytopathology, immunohistochemistry, hematopathology, and others. Furthermore, on the basis of end-user, the market is sub-segmented into academic institute, hospitals and healthcare institutions, pharmaceutical research and contract research organizations (CROs), and others. The cytopathology subcategory is expected to capture a significant portion of the market share within the application segment. The increasing population base prone to numerous diseases. Cytopathology is a specialized diagnostic procedure that examines individual cells removed from tissues to determine the source and nature of a disease.

The Scanners Sub-Segment is Anticipated to Hold a Considerable Share of the Global Whole Slide Imaging Market

Among the technology, the scanners sub-segment is expected to hold a considerable share of the global whole slide imaging market. The segmental growth is attributed to the increased demand for digital pathology across the globe. Increase in demand for digital pathology solutions remote access to slides, telepathology, and collaborative analysis are merely a few of the advantages of digital pathology. Pathologists and researchers can benefit from digital pathology by utilizing scanners such as the NanoZoomer S20MD. For instance, in March 2023, Hamamatsu Photonics, released the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU).The NanoZoomer S20MD Slide scanner system offers excellent image quality and rapid throughput, scanning 20 slides in 15 minutes. It is designed with the same pixel pathway as the high-end model and includes image acquisition and viewing software. It is additionally compliant with IVDR (EU), UKCA (UK) and IvDO (CH) regulations.

Regional Outlook

The global whole slide imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to rising awareness of the benefits of whole slide imaging, in addition to an extensive population base in some countries such as India and China, have contributed to the region's market growth.

The North America Region is Expected to Grow at a Significant CAGR in the Global Whole Slide Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the telepathology and tele-cytology development across the globe. The study's success in reaching high sensitivity and specificity rates in remote cytological evaluations emphasizes the significance of telepathology in healthcare improvement. Telepathology, that involve tele-cytology, enables pathologists to remotely access and interpret digital slides, making it easier to provide diagnosis and consultations, particularly in areas where specialist expertise is scarce. According to the MDPI, in October 2023, the prospective study analyzed 314 Rapid Remote Online Cytological Evaluations (154 imprint cytologies, 143 fine needle aspirations and 17 brush cytologies) performed on 239 patients at the LungenClinic Grosshansdorf. During on-site evaluation via tele-cytology, the time requirement was recorded and the findings were compared with the cyto-/histological and final diagnoses. The results showed that 86 cytological benign, 190 malignant and 38 unclear diagnoses were recorded. Excluding the 37 specimens with unclear diagnoses, the sensitivity rate was 90.5%, the specificity rate was 98.5% and the correct classification rate was 92.4% with regard to the final diagnosis. The sensitivity rate for the cytological detection of malignant tumors was 76.1% for fine-needle aspirations and 92.5% when excluding the 37 specimens with unclear findings.

Market Players Outlook

The major companies serving the whole slide imaging market include Leica Microsystems GmbH, Olympus Corp. Philips International B.V., NIKON CORP., Visiopharm A/S, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Infinitt collaborated with Hamamatsu, offered improved integration with NanoZoomers, allowing laboratories and pathologists to review slides in an end-to-end operational workflow. Furthermore, the integration of IDPS with LIS will allow pathologists to work more efficiently in a digital environment.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global whole slide imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. 3DHISTECH Ltd.
  • 1.1.1. Overview
  • 1.1.2. Financial Analysis
  • 1.1.3. SWOT Analysis
  • 1.1.4. Recent Developments
• 3.3. Aiforia Technologies Oyj
  • 1.1.5. Overview
  • 1.1.6. Financial Analysis
  • 1.1.7. SWOT Analysis
  • 1.1.8. Recent Developments
• 3.4. Akoya Biosciences, Inc.
  • 1.1.9. Overview
  • 1.1.10. Financial Analysis
  • 1.1.11. SWOT Analysis
  • 1.1.12. Recent Developments
• 1.2. Key Strategy Analysis

2. Market Segmentation

• 2.1. Global Whole Slide Imaging Market by Technology
  • 2.1.1. Scanners
  • 2.1.2. IT Infrastructure
  • 2.1.3. ViewerImage Management System
• 2.2. Global Whole Slide Imaging Market by Application
  • 2.2.1. Telepathology
  • 2.2.2. Cytopathology
  • 2.2.3. Immunohistochemistry
  • 2.2.4. Hematopathology
  • 2.2.5. Others(Neuropathology, and Forensic Pathology)
• 2.3. Global Whole Slide Imaging Market by End User
  • 2.3.1. Brushed Micromotor
  • 2.3.2. Brushless Micromotor
• 2.4. Global Whole Slide Imaging Market by End-User
  • 2.4.1. Academic Institute
  • 2.4.2. Hospitals and Healthcare Institutions
  • 2.4.3. Pharmaceutical Research and Contract Research Organizations (CROs)
  • 2.4.4. Others(Biotechnology and Pharmaceutical Companies, and Government Health Agencies)

3. Regional Analysis

• 3.1. North America
  • 3.1.1. United States
  • 3.1.2. Canada
• 3.2. Europe
  • 3.2.1. UK
  • 3.2.2. Germany
  • 3.2.3. Italy
  • 3.2.4. Spain
  • 3.2.5. France
  • 3.2.6. Rest of Europe
• 3.3. Asia-Pacific
  • 3.3.1. China
  • 3.3.2. India
  • 3.3.3. Japan
  • 3.3.4. South Korea
  • 3.3.5. Rest of Asia-Pacific
• 3.4. Rest of the World

4. Company Profiles

• 4.1. CureMetrix, Inc.
• 4.2. Flagship Biosciences, Inc.
• 4.3. HAMAMATSU Group
• 4.4. Huron Digital Pathology
• 4.5. Indica Labs, Inc.
• 4.6. Leica Microsystems GmbH
• 4.7. MBF Bioscience
• 4.8. Mikroscan Technologies
• 4.9. Molecular Machines & Industries GmbH
• 4.10. NIKON CORP.
• 4.11. Olympus Corp.
• 4.12. OPAL KELLY INC.
• 4.13. OptraSCAN Inc.
• 4.14. PerkinElmer AES
• 4.15. Philips International B.V.
• 4.16. Visiopharm A/S
• 4.17. Zeiss AG